Lv46
430 积分 2024-08-14 加入
Cancer statistics, 2023
12天前
已完结
Ipilimumab-associated cholestatic hepatitis: a case report and literature review
12天前
已完结
Gastrointestinal: Immune‐related sclerosing cholangitis with pembrolizumab: Imaging and histological features
18天前
已完结
Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data
18天前
已完结
Pembrolizumab-Induced Sclerosing Cholangitis
18天前
已完结
Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort
18天前
已完结
Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report
18天前
已完结
Secondary Sclerosing Cholangitis due to Drugs With a Special Emphasis on Checkpoint Inhibitors
19天前
已完结
Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system
19天前
已完结
Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System
20天前
已完结
皖公网安备34019202002308
